IRISIGHT Trademark

Trademark Overview


On Tuesday, April 26, 2022, a trademark application was filed for IRISIGHT with the United States Patent and Trademark Office. The USPTO has given the IRISIGHT trademark a serial number of 97381602. The federal status of this trademark filing is REGISTERED as of Tuesday, October 29, 2024. This trademark is owned by Variantyx Inc.. The IRISIGHT trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Genetic testing for medical purposes; Consulting services in the field of genetic testing for medical purposes; Medical and health services relating to DNA, genetics, genetic testing and genetic sequencing in the field of prenatal analysis; Providing medical information via medical reports, namely, diagnostic reports based on genetic analysis; Providing medical information to healthcare professionals on genetic variants diagnostics; Providing medical information via a website featuring information on patient genetic data for diagnosis purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical laboratory services for the analysis of samples taken from patients, namely, analysis of biological sample and genetic sequencing for diagnostic and treatment purposes; Laboratory testing services, namely, genetic testing in the field of oncology for analyzing, classifying, interpreting and diagnosing genetic data for medical diagnostic and ...

Scientific laboratory services in the field of genomics, namely, genetic sequencing, analysis and diagnosis of biological samples for analyzing, classifying, interpreting and diagnosing genetic data; Platform as a Services (PAAS) featuring computer software platforms for analyzing, classifying, interpreting and diagnosing genetic data; Platform as a Services (PAAS) featuring computer software platforms that provide a diagnostic report based on genetic analysis; Platform as a Services (PAAS) featuring computer software platforms for analyzing genetic data and providing medical information to healthcare professionals; All of the above-mentioned services in the field of reproductive health and reproductive medicine for analyzing, classifying, interpreting and diagnosing genetic data
irisight

General Information


Serial Number97381602
Word MarkIRISIGHT
Filing DateTuesday, April 26, 2022
Status700 - REGISTERED
Status DateTuesday, October 29, 2024
Registration Number7552857
Registration DateTuesday, October 29, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2023

Trademark Statements


Goods and ServicesGenetic testing for medical purposes; Consulting services in the field of genetic testing for medical purposes; Medical and health services relating to DNA, genetics, genetic testing and genetic sequencing in the field of prenatal analysis; Providing medical information via medical reports, namely, diagnostic reports based on genetic analysis; Providing medical information to healthcare professionals on genetic variants diagnostics; Providing medical information via a website featuring information on patient genetic data for diagnosis purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical laboratory services for the analysis of samples taken from patients, namely, analysis of biological sample and genetic sequencing for diagnostic and treatment purposes; Laboratory testing services, namely, genetic testing in the field of oncology for analyzing, classifying, interpreting and diagnosing genetic data for medical diagnostic and treatment purposes; All of the above-mentioned services in the field of reproductive health and reproductive medicine
Goods and ServicesScientific laboratory services in the field of genomics, namely, genetic sequencing, analysis and diagnosis of biological samples for analyzing, classifying, interpreting and diagnosing genetic data; Platform as a Services (PAAS) featuring computer software platforms for analyzing, classifying, interpreting and diagnosing genetic data; Platform as a Services (PAAS) featuring computer software platforms that provide a diagnostic report based on genetic analysis; Platform as a Services (PAAS) featuring computer software platforms for analyzing genetic data and providing medical information to healthcare professionals; All of the above-mentioned services in the field of reproductive health and reproductive medicine for analyzing, classifying, interpreting and diagnosing genetic data

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 2, 2022
Primary Code042
First Use Anywhere DateWednesday, June 1, 2022
First Use In Commerce DateWednesday, June 1, 2022

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 2, 2022
Primary Code044
First Use Anywhere DateWednesday, June 1, 2022
First Use In Commerce DateWednesday, June 1, 2022

Trademark Owner History


Party NameVariantyx Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFarmingham, MA 01701

Party NameVariantyx Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFarmingham, MA 01701

Party NameVariantyx Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFarmingham, MA 01701

Trademark Events


Event DateEvent Description
Friday, April 29, 2022NEW APPLICATION ENTERED
Monday, May 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Thursday, January 26, 2023PRIORITY ACTION WRITTEN
Thursday, January 26, 2023PRIORITY ACTION E-MAILED
Thursday, January 26, 2023NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, March 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 10, 2023FINAL REFUSAL WRITTEN
Monday, April 10, 2023FINAL REFUSAL E-MAILED
Monday, April 10, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 18, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, April 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 3, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 23, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 21, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, November 10, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, November 24, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, December 18, 2023ASSIGNED TO PETITION STAFF
Tuesday, December 19, 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, June 3, 2024USE AMENDMENT FILED
Monday, June 3, 2024TEAS STATEMENT OF USE RECEIVED
Monday, July 15, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 16, 2024STATEMENT OF USE PROCESSING COMPLETE
Saturday, September 21, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, September 21, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 29, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 29, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT